NURS 6521 ADVANCE PHARMACOLOGY WEEK8 QUIZ

A Nephrotoxicity and . hepatotoxicity B Endocarditis and hypertension . C Peripheral neuropathy . D Hyperkalemia and hyponatremia . 1 points QUESTION 2 1. An immunocompromised cancer patient has developed cryptococcal meningitis and been admitted to the intensive care unit for treatment with amphotericin B. How should the nurse most safely administer this drug? A Place the patient on a constant infusion of amphotericin B at a rate determined . by the patient's body weight. B Infuse the drug over 2 to 4 hours into a central line using an infusion pump . C Flush the patient's central line with normal saline and infuse the amphotericin B . by intravenous push over 5 to 7 minutes. D Hang the drug by piggyback with lactated Ringer's and infuse over several hours . to minimize the risk of infusion reaction 1 points QUESTION 3 1. A 20-year-old female patient is receiving topical clindamycin for acne vulgaris. She develops a rash and urticaria along with severe itching where the medication is applied. The nurse will formulate which of the following nursing diagnoses for the patient? A Risk of Injury related to blood dyscrasia . B Diarrhea . C Risk for Injury related to allergic reactions . D Imbalanced Nutrition: Less than Body Requirements . A plasma concentrations regularly. . B urine output daily. . C blood sugar levels daily. . D liver enzymes monthly. . A on an empty stomach 1 hour before or 2 hours after taking any meals or other . drugs. B with a meal. . C at bedtime only. . D with milk or fruit juice. . A immediately before or with a meal. . B with a glass of water 1 hour before or 2 hours after a meal. . C intravenously with the assistance of a home health nurse. . D with a sip of water 1 hour before mealtime. . A blood glucose levels daily for 1 week. . B liver enzymes weekly until the drug therapy is completed. . C a baseline complete blood count. . D establishing the patient's auditory abilities. . A Prothrombin time . B Serum albumin level . C Creatinine clearance . D Potassium level . A Colitis . B Arthropathy . C Hepatitis . D Hypotension . A increased intracranial pressure or changes in cognition. . B neutropenia or autoimmune effects. . C ototoxicity or nephrotoxicity. . D anemia or impaired erythropoiesis. . A Serum alanine transaminase, aspartate transaminase, and . bilirubin B Fasting blood sugar and 2-hour postprandial blood sugar . C Red blood count, white blood count, and differential . D Thyroid-stimulating hormone, thyroxine, and triiodothyronine levels . A It is safe for the patient to use topical ciprofloxacin but the oral route is potential . teratogenic. B The patient will require a lower dose and longer course of ciprofloxacin than a . nonpregnant, adult patient. C The use of ciprofloxacin is contraindicated in pregnancy. . D Ciprofloxacin is safe to use in pregnancy and the patient may use to same dose . and route as a nonpregnant patient. A twice a day. . B as needed. . C three times a day. . D once a day. . A the drug usually causes cardiac arrhythmias. . B body fluids such as urine, saliva, tears, and sputum may become discolored. . C facial flushing may appear but will go away once therapy is concluded. . D the drug frequently causes seizure activity. . A inhibiting tumor growth by enhancing inflammation. . B causing mutations in the DNA of cancerous cells. .